Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression

prnasiaJanuary 13, 2020

Tag: COMPASS , Psilocybin Formulation , Treatment-resistant Depression

PharmaSources Customer Service